تنبيه سريري تجريبي

إخلاء مسؤولية: هذه المنصات هي عمل شخصي للدكتور علي الإبراهيم، وهي في المرحلة التجريبية (بيتا) وقد تحتوي على أخطاء. يرجى الإبلاغ عن أي أخطاء أو مقترحات للتحسين إلى Alioud16@gmail.com

الغرض من الأداة ومصادرها وحدودها

مراجعة النمط القلبي وتصنيف mWHO 2.0 وفق ESC 2025 وCARPREG II، وقياسات الأبهر والدورة الرئوية ومضادات التخثر وخطة الولادة وما بعدها.

منصة مهنية في مرحلة بيتا. راجع المصادر ونطاق النموذج والوحدات قبل تفسير النتائج. لا يعني التحقق البرمجي اعتماداً سريرياً.

طرق الاستخدام ومعايير الأدلة ↗
CARDIO-OBSTETRICS · LESION, PHYSIOLOGY & CONTINUITY OF CARE

Maternal Cardiac Disease

Understand the heart. Coordinate the care.
From preconception through postpartum.

ESC 2025 · mWHO 2.0 · CARPREG IIClinical approval pending
CLINICAL ENTRY

Clinical detail. Clear priorities.

Tab moves forward; Shift+Tab returns. Enter advances text / number fields. Native select and Space keys are preserved. Ctrl / ⌘ + Enter reviews.

1 · Context & observations0 recorded

Preconception, pregnancy and postpartum are different clinical contexts. No normal findings or gestation are prefilled.

2 · Immediate safety0 recorded

Positive danger signs stay visible even if another field is invalid. A score never rules out an acute cardiac emergency.

3 · Lesion & rhythm0 recorded

Choose the precise phenotype. An uncomplicated label must be verified, not inferred from a diagnosis name.

Verify lesion-specific criteria. Fontan: good ventricular function / exercise tolerance, normal saturations, no significant valve disease / arrhythmia. Ebstein: mild–moderate TR, no tricuspid stenosis or accessory pathway. Other repairs require no significant residual lesions.
4 · Ventricular & valve data0 recorded

Current severity guides mWHO review. CARPREG II uses separately reviewed baseline predictors; the two must not be silently mixed.

5 · Aorta & pulmonary circulation0 recorded

Aortic diameter and indexed size are not interchangeable. Echo RVSP and a precapillary hemodynamic pattern do not independently diagnose PAH.

BAV, coarctation, hypertension or aortic dilatation. ASI <20 alone does not establish the uncomplicated class-II profile.
6 · CARPREG II baseline0 recorded

Original 2018 model: 10 explicitly assessed baseline predictors. No auto-checking, inference from current GA, partial-score risk percentage or mortality interpretation.

Pregnant patient with established structural cardiac disease or a clinically important cardiac arrhythmia; not a general-population screening test.
Before this pregnancy: heart failure, stroke / TIA, or an arrhythmia requiring treatment. Do not count isolated benign ectopy as a treated arrhythmia.
Baseline functional status / cyanosis, not a symptom inferred from an unchecked box or today’s gestation.
Bioprosthetic valves and aspirin use do not establish this predictor.
Original CARPREG II definition: systemic ventricular EF <55%. This threshold is not the mWHO EF threshold.
Original definitions: AVA <1.5 cm², subaortic gradient >30 mmHg, MVA <2 cm², or moderate–severe mitral regurgitation. Do not substitute ZAHARA obstruction cutoffs.
Original study: RVSP ≥50 mmHg without RV outflow obstruction. This predictor is NOT a diagnosis of PAH.
Angiographically proven coronary obstruction or previous myocardial infarction.
Marfan, Loeys–Dietz, vascular EDS, BAV aorta >45 mm, prior dissection or pseudoaneurysm. Not every aortopathy or arbitrary ≥45 mm measurement qualifies.
Yes means absence of previous cardiac intervention after record review. Unknown is not absence. This is not the same as “an intervention is not indicated”.
Strictly >20 weeks at the FIRST assessment. The current GA must never set this predictor automatically.
Confirm after reviewing the predictors; editing a predictor clears this acknowledgement. Do not mix today’s deterioration with baseline. Postpartum / preconception contexts do not generate a new pregnancy forecast.
7 · Anticoagulation & monitoring0 recorded

Medication strategy, targets and conversion timing must be explicitly prescribed by the treating team. No automatic dosing or neuraxial clearance is generated.

8 · Medication review0 recorded

Explicit medication flags, not an unreliable parser of free-text drug names. Pregnancy and breastfeeding advice differs; essential therapy must not be stopped without a safe specialist plan.

9 · Cardiology adjudication0 recorded

The displayed algorithm finds matching ESC rows; it cannot certify a complete mWHO class. Record the current clinician adjudication with its provenance.

10 · Team & surveillance0 recorded

Mark reviewed only when the actual result / consultation has been assessed. No task is automatically marked complete.

11 · Birth & postpartum handover0 recorded

Risk class alone does not determine birth date, caesarean delivery, assisted second stage or a fixed postpartum discharge time.

MATERNAL SAFETY · CONTINUITY OF CARE

Start with context and maternal safety

From preconception to postpartum: understand the lesion, assess the present state, and coordinate the plan.

CURRENT CONTEXT—No gestation assumed
HIGHEST MATCHED ESC ROWUnresolvedProvisional · not a complete final class
CARPREG IIIncomplete0/10 predictors assessed

Care coordination

Build a lesion-specific surveillance plan

Review ECG, current echo / ventricular and valve data, oxygenation and symptoms. Agree test / visit intervals with cardiology rather than assigning a universal 2-week / 4-week schedule. BNP or NT-proBNP trends require assay, phase and clinical interpretation; no universal cutoff is fabricated.

ESC 2025 · Cardiovascular disease and pregnancy ↗
4 unresolved assessment items
  • Record whether this is preconception, pregnancy or postpartum.
  • 8 acute safety findings not assessed; unchecked / unknown is not normal.
  • Current cardiac phenotype / imaging is unverified; lower-risk mWHO rows cannot be certified.
  • Exact medication reconciliation is not recorded.

Current clinician adjudication

Not yet verified. A matched algorithm row is not a complete clinician classification.

No valid current case report available.

New case entries stay in this page’s memory; no case storage or transmission is introduced. Reload / reset clears the current in-memory case. Saved cases from previous versions are not loaded. Copied, exported and printed records remain under your control.

Clear this input section?

Fields in this section return to blank / unknown. Other sections remain; verify the retained context and planning details. The handover acknowledgement will be cleared.

A safe route through cardiac pregnancy

100%
Educational clinical workflow showing acute danger signs first, then two separate tracks: current lesion-specific ESC mWHO review and fully assessed baseline CARPREG II. Both feed a Pregnancy Heart Team care plan that continues through birth and postpartum.

An acute safety finding takes priority. Today’s clinical status, the highest matched ESC row, baseline prediction and clinician adjudication answer different questions. None substitutes for the others.

Educational illustrations · Educational only · Not to scale · Clinical approval pending.

معلومات المنصة والمراجع

Version: 2.0 local review
Guideline version: ESC 2025 / mWHO 2.0; CARPREG II (2018); ESC/ERS PH 2022
Last reviewed date: 20 October 2026
Formula source: Original CARPREG II weights / cohort mapping; Mosteller BSA; ASI = aortic mm / BSA m²
Coefficient source: CARPREG II requires all ten baseline predictors; no ZAHARA calculation claimed
Validation notes: Local automated / browser review; independent cardiology / MFM / anesthesia approval required
Known limitations: Selected phenotype mapping is provisional, not a complete mWHO classification. No automatic PAH diagnosis, medication dose, neuraxial clearance, delivery timing or discharge decision. Unknown is not normal. No saved-case import.
What changed in this version: Controlled React rebuild; contemporary ESC rows; full-predictor baseline scoring; independent acute safety; indexed aorta / RHC / anticoagulation review; phase-specific medicines; coordinated birth / postpartum planning; accessible keyboard / reset workflow; current-case drafts; educational diagrams.
© 2026 Dr. Ali Hussein Al Ibrahim. All rights reserved.